[go: up one dir, main page]

AU5014285A - Method for reducing the risk or probability of infection fromthe aids virus (htlv-iii/lav/arv) - Google Patents

Method for reducing the risk or probability of infection fromthe aids virus (htlv-iii/lav/arv)

Info

Publication number
AU5014285A
AU5014285A AU50142/85A AU5014285A AU5014285A AU 5014285 A AU5014285 A AU 5014285A AU 50142/85 A AU50142/85 A AU 50142/85A AU 5014285 A AU5014285 A AU 5014285A AU 5014285 A AU5014285 A AU 5014285A
Authority
AU
Australia
Prior art keywords
arv
lav
htlv
fromthe
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU50142/85A
Inventor
William Sergio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SERGIO W
Original Assignee
SERGIO W
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SERGIO W filed Critical SERGIO W
Publication of AU5014285A publication Critical patent/AU5014285A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/315—Zinc compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU50142/85A 1985-10-21 1985-10-24 Method for reducing the risk or probability of infection fromthe aids virus (htlv-iii/lav/arv) Abandoned AU5014285A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78932485A 1985-10-21 1985-10-21
US789324 1985-10-21

Publications (1)

Publication Number Publication Date
AU5014285A true AU5014285A (en) 1987-05-05

Family

ID=25147296

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50142/85A Abandoned AU5014285A (en) 1985-10-21 1985-10-24 Method for reducing the risk or probability of infection fromthe aids virus (htlv-iii/lav/arv)

Country Status (3)

Country Link
EP (1) EP0243352A1 (en)
AU (1) AU5014285A (en)
WO (1) WO1987002246A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8906190D0 (en) * 1989-03-17 1989-05-04 Johnson Matthey Plc Improvements in chemical compounds
US5208031A (en) * 1989-06-06 1993-05-04 Kelly Patrick D Sexual lubricants containing zinc as an anti-viral agent
US5785054A (en) * 1989-06-06 1998-07-28 Kelly; Patrick D. Genital lubricant with zinc salt, labelled as anti-viral agent
EP0402078A3 (en) * 1989-06-06 1991-07-31 Patrick Daniel Kelly Sexual lubricants containing zinc as an anti-viral agent
US5624675A (en) * 1989-06-06 1997-04-29 Kelly; Patrick D. Genital lubricants containing zinc salts to reduce risk of HIV infection
US5482053A (en) * 1989-06-06 1996-01-09 Kelly; Patrick D. Condom lubricants containing zinc as an anti-viral agent
US5545673A (en) * 1989-06-06 1996-08-13 Kelly; Patrick D. Method for reducing risk of infection by sexually transmitted viruses
US5599551A (en) * 1989-06-06 1997-02-04 Kelly; Patrick D. Genital lubricants containing zinc as an anti-viral agent
DE4302053C1 (en) * 1993-01-26 1994-06-30 Gunther Dr Kuemel Synergistic compsn. for preventing HIV infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2245374B1 (en) * 1973-07-27 1977-02-25 Anvar
SE7607496L (en) * 1976-07-01 1978-01-02 Astra Laekemedel Ab METHOD FOR FIGHTING VIRUS INFECTIONS
LU77562A1 (en) * 1977-06-17 1979-03-26 Ciba Geigy Ag METHOD FOR PRODUCING NEW PHARMACEUTICAL PREPARATIONS

Also Published As

Publication number Publication date
EP0243352A1 (en) 1987-11-04
WO1987002246A1 (en) 1987-04-23

Similar Documents

Publication Publication Date Title
PL268266A1 (en) The method of manufacture of proteins env virus aids
AU589732B2 (en) Process for the preparation of 2-oxo-1,3-dioxolanes
AU597635B2 (en) Treatment of diseases caused by retroviruses
AU6713287A (en) Expression of htlv-iii gag-gene
AU8171987A (en) Blood separator
AU6518890A (en) 6-amino-1,2-benzopyrones useful for treatment of viral diseases
AU5553290A (en) Dissemination of hiv-1 infected cells
AU588102B2 (en) Process for the preparation of LMW-heparin
AU7044087A (en) Crop treatment processes
AU8297787A (en) 1h-imadazole-5-carboxylic acid derivatives
AU8292687A (en) Thiol-carboxylic acid derivatives
AU6979487A (en) Treatment of gases
AU587108B2 (en) Imidazolecarboxylic acid derivatives
AU7250887A (en) Detection of htlv-iii infected cells
AU5014285A (en) Method for reducing the risk or probability of infection fromthe aids virus (htlv-iii/lav/arv)
AU1193988A (en) Method of inhibiting the transmission of aids virus
AU5568290A (en) Method of suppressing hiv infection
AU5419690A (en) Treatment of aids dementia, myelopathy and blindness
AU581558B2 (en) Gas treatment process
AU7760887A (en) Stereoisomers of phenylethano/amine derivatives
AU4328189A (en) Bile acids for treatment of viral infections
AU1811388A (en) Method of treatment for retroviral infectious diseases
AU7527487A (en) Process for the preparation of isethionic acid
AU7360387A (en) Bacteriocins used for anti-viral treatment (particularly aids)
AU6674290A (en) Methods of treating retroviral infection